Results of HLA class I typing in 2020
| Trials | Specimen | Resolution | HLA-A | No. of labs | HLA-B | No. of labs | HLA-C | No. of labs |
|---|---|---|---|---|---|---|---|---|
| 1st | IHL-20-01 | Generic type | A*02/A*24 | 66 | B*40/B*51 | 66 | C*03/C*14 | 40 |
| Allelic type | A*02:01/A*24:02 | 25 | B*40:02/B*51:01 | 25 | C*03:03/C*14:02 | 24 | ||
| A*02:01G/A*24:02G | 3 | B*51:01G/B*40:02G | 3 | C*03:03G/C*14:02G | 3 | |||
| Serological equivalent | A2/A24 | 66 | B51/B61 | 66 | Cw1/Cw9 | 1 | ||
| Cw3/Blank | 2 | |||||||
| Cw9/Blank | 33 | |||||||
| Cw9/Cw1/Blank | 1 | |||||||
| Cw9/Cw14 | 4 | |||||||
| IHL-20-02 | Generic type | A*02/A*33 | 66 | B*44/B*59 | 66 | C*01/C*14 | 40 | |
| Allelic type | A*02:06/A*33:03 | 24 | B*44:03/B*59:01 | 25 | C*01:02/C*14:03 | 24 | ||
| A*02:06/A*33:03G | 1 | B*44:03G/B*59:01G | 3 | C*01:02G/C*14:03 | 1 | |||
| A*02:06G/A*33:03G | 3 | C*01:02G/C*14:03G | 2 | |||||
| Serological equivalent | A2/A33 | 66 | B44/B59 | 66 | Cw1/Blank | 37 | ||
| Cw1/Cw14 | 4 | |||||||
| 2nd | IHL-20-03 | Generic type | A*26/A*33 | 67 | B*15/B*46/ | 67 | C*01/C*03 | 39 |
| Allelic type | A*26:02/A*33:03 | 24 | B*15:01/B*46:01 | 25 | C*01:02/C*03:03 | 24 | ||
| A*26:02/A*33:03G | 4 | B*46:01G/B*15:01G | 3 | C*01:02G/C*03:03G | 3 | |||
| Serological equivalent | A26/A33 | 67 | B46/B62 | 67 | Cw1/Cw9 | 40 | ||
| IHL-20-04 | Generic type | A*01/A*02 | 67 | B*54 | 3 | C*01 | 1 | |
| B*54/Blank | 64 | C*01/Blank | 39 | |||||
| Allelic type | A*01:01/A*02:01 | 25 | B*54:01/B*54:01 | 4 | C*01:02/C*01:02 | 4 | ||
| A*01:01G/A*02:01G | 3 | B*54:01/B*99:99 | 21 | C*01:02/C*99:99 | 20 | |||
| B*54:01G/B*54:01G | 1 | C*01:02G/C*01:02G | 1 | |||||
| B*54:01G/B*99:99 | 2 | C*01:02G/C*99:99 | 2 | |||||
| Serological equivalent | A1/A2 | 67 | B54 | 3 | Cw1 | 1 | ||
| B54/Blank | 64 | Cw1/Blank | 39 |
Bold letter indicates the results which are not compliant with the intended responses.
Abbreviation: HLA, human leukocyte antigen.